Tuberculosis in the era of anti-TNF-alpha therapy: Why does the risk still exist?

John Leonardo Torres-Castiblanco, Jorge Alberto Carrillo, Daniel Hincapié-Urrego, Adriana Rojas-Villarraga

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Tuberculosis in the era of anti-TNF-alpha therapy: Why does the risk still exist?'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds